Pirfenidone gel in patients with localized scleroderma: a phase II study
نویسندگان
چکیده
منابع مشابه
Pirfenidone gel in patients with localized scleroderma: a phase II study
INTRODUCTION Localized scleroderma is an inflammatory disease in its first stages and a fibrotic process in later stages, principally mediated by the transforming growth factor β. To date, there is no standard treatment. The objective of this study was to determine the effectiveness and safety of 8% pirfenidone gel in patients with localized scleroderma. METHODS This was an open phase II clin...
متن کاملAn Open-label, Phase II Study of the Safety and Tolerability of Pirfenidone in Patients with Scleroderma-associated Interstitial Lung Disease: the LOTUSS Trial.
OBJECTIVE Systemic sclerosis-associated interstitial lung disease (SSc-ILD) shares a number of clinical features and pathogenic mechanisms with idiopathic pulmonary fibrosis (IPF). This study was designed to evaluate the tolerability of the IPF treatment pirfenidone in SSc-ILD. The known gastrointestinal, skin, and liver adverse events (AE) of pirfenidone are of importance given the involvement...
متن کاملA phase II pharmacodynamic study of preoperative figitumumab in patients with localized prostate cancer.
PURPOSE Activation of the insulin-like growth factor 1 receptor (IGF-IR) is implicated in prostate cancer development and progression. This study evaluated biologic and clinical effects of figitumumab, a fully human monoclonal IGF-IR antibody, in patients with localized prostate cancer. EXPERIMENTAL DESIGN Eligible patients received figitumumab 20 mg/kg intravenously every 3 weeks for 3 cycle...
متن کاملAnti-phosphatidylserine-prothrombin complex antibodies in patients with localized scleroderma.
OBJECTIVE Although some antiphospholipid antibodies (Abs) are found in patients with localized scleroderma (LSc), Ab against phosphatidylserine-prothrombin complex (PS/PT) has not been examined. We investigated anti-PS/PT Ab levels in patients with LSc. METHODS IgG anti-PS/PT Ab levels in serum samples taken from patients with LSc (n = 42) were measured using ELISA. RESULTS IgG anti-PS/PT A...
متن کاملPrimary localized cutaneous amyloidosis in patients with scleroderma.
Primary localized cutaneous amyloidosis (PLCA) is a relatively rare condition characterized by amyloid de-position exclusively in the dermis without involving the internal organs. Clinically, papular, macular and tumefac-tive forms are presented. Although PLCA may sometimes overlap with collagen vascular diseases, association with scleroderma is rare. We report here two cases of PLCA developing...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Arthritis Research & Therapy
سال: 2014
ISSN: 1478-6354
DOI: 10.1186/s13075-014-0510-4